Deletions and rearrangements inactivate the p16INK4 gene in human glioma cells

Oncogene

Volumn 12, Issue 9, 1996, Pages 2029-2034

  Srivenugopal, Kalkunte S ^a   Ali Osman, Francis ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

CdK inhibitor; Cell cycle; Human glioma; p16INK4; Retinoblastoma protein

Indexed keywords

MESSENGER RNA; RETINOBLASTOMA PROTEIN;

ARTICLE; CELL CYCLE; EXON; GENE AMPLIFICATION; GENE DELETION; GENE REARRANGEMENT; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; SOUTHERN BLOTTING;

BLOTTING, SOUTHERN; BRAIN NEOPLASMS; CARRIER PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENE DELETION; GENE REARRANGEMENT; GLIOMA; HUMANS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0030002649     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ali-Osman F, Spence AM, Berger MS and Caughlan J. (1987). J. Neuropath and Exp. Path., 46, 371-375.
2. Ali-Osman F, Stein DE and Renwick A. (1990). Cancer Res., 50, 6976-6980.
3. Arap W, Nishikawa R, Furnari FW, Cavanee WK and Su-Huang H-J. (1995). Cancer Res., 55, 1351-1354.
4. Cairns P, Mao L, Merlo A, Lee D, Schwab D, Eby Y, Tokino K, van der Riet P, Blaugrund J and Sidransky D. (1994). Science, 265, 415-416.
5. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ and Kern SE. (1994). Nature Genetics, 8, 27-32.
6. Chomczynski P and Sacchi N. (1987). Anal. Biochem., 162, 156-159.
7. Duro D, Bernard O, Valle VD, Berger R and Larsen C-J. (1995). Oncogene, 11, 21-29.
8. Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM and Jones PA. (1995). Cancer Res., 55, 4531-4535.
9. Hannon GJ and Beach D. (1994). Nature, 371, 257-261.
10. He J, Allen JR, Collins VP, Allalunis-Turner MJ, Godbout R, Day III, RS and James CD. (1994). Cancer Res., 54, 5804-5807.
11. Hebert J, Cayuela JM, Berkeley J and Sigaux F. (1994). Blood, 84, 4038-4044
12. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JPG, Davidson NE, Sidransky D and Baylin S. (1995). Cancer Res., 55, 4525-4530.
13. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally DS, Sheahan D, Clark WH, Tucker MA and Dracopoli NC. (1994). Nature Genetics, 8, 15-21.
14. Jen J, Harper W, Bigner SH, Bigner DD, Papadopoulos N, Markowitz, S, Willson JKV, Kinzler KW and Vogelstein B. (1994). Cancer Res., 54, 6353-6358.
15. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson BE and Skolnick MH. (1994a). Science, 264, 436-440.
16. Kamb A, Liu Q, Harshman K and Tavtigian S. (1994b). Science, 265, 416-417.
17. Kato J, Matsushime H, Hiebert SW, Ewen ME and Sherr CJ. (1993). Genes Dev., 7, 331-342.
18. Li Y, Nichols MA, Shay JW and Xiong Y. (1994). Cancer Res., 54, 6078-6082.
19. Li Y J, Hoang-Xuan K, Delattre J-Y, Poisson M, Thomas G and Hamelin R. (1995). Oncogene, 11, 597-600.
20. Liu Q, Neuhausen S, McClure M, Frye C, Weaver-Feldhaus J, Gruis NA, Eddington K, Allaunis-Turner MJ, Skolnick MH, Fujimura FK and Kamb A. (1995). Oncogene, 10, 1061-1067.
21. Mao L, Merlo A, Bedi G, Shapiro GI, Edwards CD, Rollins BJ and Sidransky D. (1995). Cancer Res., 55, 2995-2997.
22. Mead LJ, Gillespie MT, Irving LB and Campbell LJ. (1994). Cancer Res., 54, 2307-2309.
23. Mori T, Miura K, Aoki T, Nishihira T, Mori S and Nakamura Y. (1994). Cancer Res., 54, 3396-3397.
24. Nishikawa R, Furnari FB, Lin H, Arap W, Berger MS, Cavanee WK and Su Huang H-J. (1995) Cancer Res., 55, 1941-1945.
25. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA. (1994). Nature, 368, 753-756.
26. Okamoto A, Demetrick DJ, Spillare EA, Hagiwara K, Hussain P, Bennett WP, Forrester K, Gerwin B, Serrano M, Beach DH and Harris CC. (1994). Proc. Natl. Acad. Sci. USA, 91, 11045-11049
27. Otterson GA, Kratzke RA, Coxon A, Kim YW and Kaye FJ. (1994). Oncogene, 9, 3375-3378.
28. Otterson GA, Khleif SN, Chen W, Coxon AB and Kaye FJ. (1995). Oncogene, 11, 1211-1216.
29. Schmidt EE, Ichimura K, Reifenberger G and Peter Collins V. (1994). Cancer Res., 54, 6321-6324
30. Serrano M, Hannon GJ and Beach D. (1993). Nature, 366, 704-707.
31. Serrano M, Gomez-lahoz E, DePinho RA, Beach D and Bar-Sagi D. (1995). Science, 267, 249-252.
32. Spruck CH III, Gonzalez-Zulueta M, Shibata A, Simoneau A, Lin M, Gonzales F, Tsai YA and Jones PA. (1994). Nature, 370, 183-184.
33. Sonoda Y, Yoshimoto T and Sekiya T. (1995). Oncogene, 11, 2145-2149.
34. Stone S, Dayananth P, Jiang P, Weaver-Feldhaus JM, Tavtigian SV, Cannon-Albright L and Kamb A. (1995a). Oncogene, 11, 987-991.
35. Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, Peters G and Kamb A. (1995b). Cancer Res., 55, 2988-2994.
36. Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A and Louis DN. (1996). Cancer Res., 56, 150-153.
37. Walker DG, Duan W, Popovic EA, Kaye AH, Tomlinson FH and Lavin M. (1995). Cancer Res., 55, 20-23.
38. Xiong Y, Zhang H and Beach D. (1993) Genes Dev., 7, 1572-1583.
39. Xu L, Sgroi D, Sterner CJ, Beauchamp, RL, Pinney DM, Keel S, Ueki K, Rutter JL, Buckler AJ, Louis DN, Gusella JF and Ramesh V. (1994). Cancer Res., 54, 5262-5264.
40. Yeudall WA, Crawford RY, Ensley JF and Robbins KC. (1994). Carcinogenesis, 15, 2683-2686.